Rapid Dose Therapeutics Corp. reported earnings results for the second quarter and six months ended August 31, 2021. For the second quarter, the company reported sales was CAD 0.32464 million compared to CAD 0.003579 million a year ago. Net loss was CAD 0.539439 million compared to CAD 0.44212 million a year ago. Basic loss per share from continuing operations was CAD 0.006 compared to CAD 0.005 a year ago. For the six months, sales was CAD 0.455838 million compared to CAD 0.003816 million a year ago. Net loss was CAD 0.410814 million compared to CAD 0.937374 million a year ago. Basic loss per share from continuing operations was CAD 0.005 compared to CAD 0.012 a year ago.